BVL-12356-16633
4 vaccinations
2 coded responses
32 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
E5Z-27925-79022
Child or adolescent in my care · Male · 2022-06-26
C7B-16490-17457
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Pfizer-BioNTech
- 2021-03-07
- 2021-03-08
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-21
- 2021-03-28
-
2021-04-04
Dose 2 — Pfizer-BioNTech
- 2021-04-04
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-13
- 2021-04-19
- 2021-04-25
- 2021-05-02
-
2021-05-09
Survey response — day 35, dose 2MedDRA: Rash — Feeling: GoodFree text: Rash on arms and legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-16
- 2021-07-04
- 2021-10-03
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2022-04-04
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-28
- 2022-09-30
- 2022-10-09
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-12-18
-
2023-03-17
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-17
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-04-04 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 35, dose 2
Symptoms: Rash on arms and legs
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release